18 November 2017
News and Views
Links and Services
The latest issue of the International Journal of Colorectal Disease reports on overall and KRAS-specific results of combined cetuximab treatment and chemotherapy for metastatic colorectal cancer.
Dr Linlin Zhang and colleagues compared the efficacy and toxicities of cetuximab
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors